Skip to main content
 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 15, 2026
Expenses
$596,609
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Opioid Abuse - General issues related to access to medication assisted treatment General Issues Related to report language regarding paper inserts

General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain General Issues Related to Proposed Physician Fee Schedule Rule

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem